Evaluation of Effectiveness of Risk Communication for Medication Therapy

DOI Web Site 1 References

Bibliographic Information

Other Title
  • 薬物治療におけるリスクコミュニケーションの課題と評価の試み
  • ヤクブツ チリョウ ニ オケル リスク コミュニケーション ノ カダイ ト ヒョウカ ノ ココロミ

Search this article

Abstract

In order to promote safe and confident use of medicine, it is essential to share information on adverse events of the product itself as well potential risks associated with the use of medicine, among the patients, family members of patients, healthcare practitioners, pharmaceutical companies and regulatory agencies. This is especially important to assure that risk communication is appropriately conducted to minimize risks.<br>Risk communication of medical products is usually followed four steps.<br>a. Planning of the content of risk communication based on collection and analysis of safety information<br>b. Execution of actions to share risk information among the relevant playerspatients, healthcare practitioners, pharmaceutical companies, regulatory agencies<br>c. Evaluation of risk communication based on monitoring of actions and its results<br>d. Planning and actions for improving effectiveness of communication<br>Nevertheless, there remain issues to be resolved in each of the four steps. Especially as no methods for evaluation of risk communication has been established yet, it is critical to prepare such guidelines quickly in order to promote standard risk communication as common practice.<br>As one of the practicable ways to resolve this issue, we have attempted to evaluate the results of conveying information from regulatory agencies and pharmaceuticals companies to healthcare practitioners by analyzing prescription data (National Prescription Audit data) as well as the frequency of access by healthcare practitioners to search safety information on drugs before and after the notification of revision drug precautions. The result of this analysis conducted for two products, showed evidence that of physicians prescription have changed as the frequency of access to search for safety information increase after notification of revision of drug precautions.<br>In conclusion, the effectiveness of risk communication must evolve quickly by initially establishing the methods and standard procedures of transferring safety information to healthcare practitioners. Simultaneously, awareness to minimize risks should be effectively built through mutual communication among the stakeholders participating in team treatment including the patient.

Journal

  • Iryo To Shakai

    Iryo To Shakai 21 (1), 41-53, 2011

    The Health Care Science Institute

References(1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top